Incidence of Age-Related Macular Degeneration in the Central Region of Portugal: The Coimbra Eye Study – Report 5
暂无分享,去创建一个
J. Cunha-Vaz | L. Ribeiro | J. Figueira | S. Nunes | Isabel A Pires | Dalila Alves | M. L. Cachulo | Rufino Silva | Patrícia Barreto | A. Martins | J. Marques | José F Costa | Cláudia Farinha | I. Laíns | Isa Sobral
[1] L. Ribeiro,et al. Adherence to a Mediterranean diet, lifestyle and age‐related macular degeneration: the Coimbra Eye Study – report 3 , 2018, Acta ophthalmologica.
[2] J. Dartigues,et al. Incidence of and Risk Factors Associated With Age-Related Macular Degeneration: Four-Year Follow-up From the ALIENOR Study , 2018, JAMA ophthalmology.
[3] Glenn J Jaffe,et al. Consensus Definition for Atrophy Associated with Age-Related Macular Degeneration on OCT: Classification of Atrophy Report 3. , 2017, Ophthalmology.
[4] P. Mitchell,et al. Six-Year Incidence of Age-Related Macular Degeneration in Asian Malays: The Singapore Malay Eye Study. , 2017, Ophthalmology.
[5] Nisha V. Shah,et al. Six-Year Incidence and Progression of Age-Related Macular Degeneration in Kenya , 2017, JAMA ophthalmology.
[6] Inês Laíns,et al. Automated Brightness and Contrast Adjustment of Color Fundus Photographs for the Grading of Age-Related Macular Degeneration , 2017, Translational vision science & technology.
[7] J. Cunha-Vaz,et al. Age‐related macular degeneration in Portugal: prevalence and risk factors in a coastal and an inland town. The Coimbra Eye Study – Report 2 , 2016, Acta ophthalmologica.
[8] P. Mitchell,et al. The Incidence and Progression of Age-Related Macular Degeneration over 15 Years: The Blue Mountains Eye Study. , 2015, Ophthalmology.
[9] D. Cook,et al. Incidence of Late-Stage Age-Related Macular Degeneration in American Whites: Systematic Review and Meta-analysis. , 2015, American journal of ophthalmology.
[10] J. Cunha-Vaz,et al. Prevalence of Age-Related Macular Degeneration in Portugal: The Coimbra Eye Study - Report 1 , 2014, Ophthalmologica.
[11] R. Klein,et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. , 2014, The Lancet. Global health.
[12] Gabriëlle H S Buitendijk,et al. Harmonizing the Classification of Age-related Macular Degeneration in the Three-Continent AMD Consortium , 2014, Ophthalmic epidemiology.
[13] M. Costa,et al. Ocular Risk Factors for Exudative AMD: A Novel Semiautomated Grading System , 2013, ISRN ophthalmology.
[14] Usha Chakravarthy,et al. Clinical classification of age-related macular degeneration. , 2013, Ophthalmology.
[15] J. Jonas,et al. Five-year incidence of age-related macular degeneration: the Beijing Eye Study. , 2012, Ophthalmology.
[16] Y. Kiyohara,et al. Nine-year incidence and risk factors for age-related macular degeneration in a defined Japanese population the Hisayama study. , 2009, Ophthalmology.
[17] Ronald Klein,et al. Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study. , 2007, Ophthalmology.
[18] Ronald Klein,et al. A simplified severity scale for age-related macular degeneration: AREDS Report No. 18. , 2005, Archives of ophthalmology.
[19] G. Jensen,et al. 14-year incidence, progression, and visual morbidity of age-related maculopathy: the Copenhagen City Eye Study. , 2005, Ophthalmology.
[20] H. Taylor,et al. Five-year incidence of age-related maculopathy: the Visual Impairment Project. , 2004, Ophthalmology.
[21] T. Peto,et al. 5-year incidence of age-related maculopathy in the Reykjavik Eye Study. , 2003, Ophthalmology.
[22] R. Klein,et al. Risk factors for incident age-related macular degeneration: pooled findings from 3 continents. , 2003, Ophthalmology.
[23] A. Hofman,et al. The risk and natural course of age-related maculopathy: follow-up at 6 1/2 years in the Rotterdam study. , 2003, Archives of ophthalmology.
[24] R. Klein,et al. Ten-year incidence and progression of age-related maculopathy: The Beaver Dam eye study. , 2002, Ophthalmology.
[25] Paul Mitchell,et al. Five-year incidence of age-related maculopathy lesions: the Blue Mountains Eye Study. , 2002, Ophthalmology.
[26] M G Maguire,et al. Five-year incidence and disappearance of drusen and retinal pigment epithelial abnormalities. Waterman study. , 1995, Archives of ophthalmology.
[27] P T de Jong,et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration , 1995 .
[28] R. Klein,et al. The Wisconsin age-related maculopathy grading system. , 1991, Ophthalmology.
[29] Paul Mitchell,et al. Ten-year incidence and progression of age-related maculopathy: the blue Mountains Eye Study. , 2007, Ophthalmology.
[30] A Hofman,et al. Incidence and progression rates of age-related maculopathy: the Rotterdam Study. , 2001, Investigative ophthalmology & visual science.
[31] R. Klein,et al. The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study. , 1997, Ophthalmology.
[32] J M Gibson,et al. Seven year follow-up of age-related maculopathy in an elderly British population , 1997, Eye.